ArticleEuropean radiology2026
Deep learning-based image enhancement for improved black blood imaging in brain metastasis.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
Abstract
objectivesTo evaluate the utility of a deep learning (DL)-based image enhancement for improving the image quality and diagnostic performance of 3D contrast-enhanced T1-weighted black blood (BB) MR imaging for brain metastases. MATERIALS AND
methodsThis retrospective study included 126 patients with and 121 patients without brain metastasis who underwent 3-T MRI examinations. Commercially available DL-based MR image enhancement software was utilized for image post-processing. The signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) of enhancing lesions were measured. For qualitative assessment and diagnostic performance evaluation, two radiologists graded the overall image quality, noise, and artifacts of each image and the conspicuity of visible lesions. The Wilcoxon signed-rank test and regression analyses with generalized estimating equations (GEEs) were used for statistical analysis.
resultsFor MR images that were not previously processed using other DL-based methods, SNR and CNR were higher in the DL-enhanced images than in the standard images (438.3 vs. 661.1, p < 0.01; 173.9 vs. 223.5, p < 0.01). Overall image quality and noise were improved in the DL images (p < 0.01, average score-5 proportion 38% vs. 65%; p < 0.01, 43% vs. 74%), whereas artifacts did not significantly differ (p ≥ 0.07). Sensitivity was increased after post-processing from 79 to 86% (p = 0.02), especially for lesions smaller than 5 mm (69 to 78%, p = 0.03), and changes in specificity (p = 0.24) and average false-positive (FP) count (p = 0.18) were not significant.
conclusionDL image enhancement improves the image quality and diagnostic performance of 3D contrast-enhanced T1-weighted BB MR imaging for the detection of small brain metastases. KEY POINTS: Question Can deep learning (DL)-based image enhancement improve the image quality and diagnostic performance of 3D contrast-enhanced T1-weighted black blood (BB) MR imaging for brain metastases? Findings DL-based image enhancement improved image quality of thin slice BB MR images and sensitivity for brain metastasis, particularly for lesions smaller than 5 mm. Clinical relevance DL-based image enhancement on BB images may assist in the accurate diagnosis of brain metastasis by achieving better sensitivity while maintaining comparable specificity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.